Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
Abgenix, AC, accuracy, adequacy, aeroallergen, Allergan, alter, Alzheimer, AMG, antihormonal, APIC, arrive, assigned, Astra, AstraZeneca, automatically, Barr, BCIRG, benchmark, billing, boxed, brining, broader, Cambridge, capecitabine, captured, category, CGI, chosen, cisplatin, daily, Dastgheib, death, delegate, deliverable, derecognition, disability, dispensing, Disproportionate, disproportionately, ditosylate, DLBCL, DMARD, domestic, DSH, edema, EITF, encouraging, ethyl, exact, extrapolate, flattened, flattening, fluoropyrimidine, Forest, forfeited, formula, Gemzar, Genmab, Genzyme, Gilead, Gleevec, Graph, Green, GSK, guide, HERA, Hillsboro, household, Humax, illustrate, imatinib, immunotherapy, imposed, indigent, inflow, Inotek, interferon, interim, intermediary, irrespective, Judge, keyton, Kineret, King, Kourosh, language, Leave, leaving, Letter, Macugen, Magistrate, mantle, MEK, mesylate, methyl, moderate, moderately, monoclonal, monthly, Mylan, Nonqualified, notably, occlusion, Ofatumumab, Omnitrope, Oregon, Orencia, paragraph, PARP, Pennsylvania, Pension, perennial, perpetual, PFS, pharmacy, plateau, point, poly, polymerase, pool, Poor, preceding, precisely, problem, proceed, purported, radiographic, radioimmunotherapy, rare, reactivity, rectal, recurrent, regular, reinvested, remanding, requisite, resubmit, retiree, retrospectively, sabbatical, saleable, Sandoz, satisfaction, Seattle, securitization, shelf, simplified, Singapore, skin, stand, startup, steroid, Stiefel, sum, switched, switching, Task, Telcyta, Telik, theory, tool, triamcinolone, Tykerb, Umbrella, uncertainty, unexercised, unpatentable, unsecured, unvested, upper, VAR, Vectibix, vein, visit, Visudyne, vitro, voluntary, warehousing, warning, waste, Watson, withdrawn, women, Xyotax, Zactima, Zeneca
Removed:
acceptance, administered, Aggregated, alleged, allergy, allocating, assembled, biology, breach, Carlo, cessation, charter, Chiron, consisting, debtor, declared, defending, delivery, directed, discontinued, diversification, dividend, dosage, exchangeable, exclusively, feature, field, finalized, FOLFOX, foreseeable, hedgehog, historic, hypothetical, initiated, interference, interruption, investee, IRS, lock, matched, mentioned, modeled, modeling, modification, Monte, nonrecourse, Northern, occurring, originally, participated, peanut, prescribing, principally, processing, prolonged, Protropin, push, reallege, redeclared, region, repaid, repay, reteplase, scenario, simple, somatrem, subordinated, tangible, temporarily, terminated, territory, trained, training, transferable, unclear, wastage, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 10.27 First Amendment to Master Lease Agreement and First Amendment to Building Leases Between Genentech and Slough SSF, LLC, Dated October 2, 2006
- 10.32 Second Amendment to the Manufacturing and Supply Agreement Between Genentech and Lonza Biologics PLC, Effective As of 19 May 2006
- 10.33 Third Amendment to the Manufacturing and Supply Agreement Between Genentech and Lonza Biologics PLC, Dated As of November 6, 2006
- 10.38 Agreement and Plan of Merger by and Among Genentech, Inc., Green Acquisition Corporation and Tanox, Inc., Dated As of November 9, 2006
- 10.39 Form of Voting Agreement Between Genentech, Inc. and Certain Stockholders of Tanox, Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
Genentech similar filings
Filing view
External links